Phoebe Koch, MD
Dermatology · Bozeman, MTNPI 1194907741
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 48.7% of the total. Reporting peaked in 2021 at $558 and has fallen 83.4% since, to $93 in 2025.
Across 131 payments — averaging $15.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$988
- Pfizer$224
- E.r. Squibb & Sons, L.L.C.$169
- Sanofi$121
- LEO Pharma Inc.$78
- Prugen, Inc. Pharmaceuticals$77
- plus $373 from 15 others
What the payments were for
- Food & beverage$2,030100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 75 | $988 |
| Pfizer | 15 | $224 |
| E.r. Squibb & Sons, L.L.C. | 8 | $169 |
| Sanofi | 6 | $121 |
| LEO Pharma Inc. | 3 | $78 |
| Prugen, Inc. Pharmaceuticals | 2 | $77 |
| Kyowa Kirin, Inc. | 4 | $60 |
| Amgen | 2 | $50 |
| UCB, Inc. | 3 | $41 |
| Novartis | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Biofrontera Inc. | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
| Incyte Corporation | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Organogenesis Inc. | 1 | $13 |
How this compares
$2,030 in reported general payments places this provider in the 60th percentile of 46 dermatology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 14 | $120,327 |
| Dupixent SyringeDupilumab | 11 | $38,898 |
| Clobetasol Propionate | 58 | $1,471 |
| Triamcinolone Acetonide | 151 | $1,263 |
| Minocycline Hcl | 23 | $946 |
| Ketoconazole | 41 | $656 |
| ValacyclovirValacyclovir Hcl | 30 | $650 |
| Fluocinonide | 18 | $511 |
| Doxycycline Monohydrate | 13 | $316 |
| Cephalexin | 24 | $132 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Bozeman
- Tara OetkenBozeman$7K
- Aaron BruceBozeman$5K
- Teresa MannBozeman$5K
- Ashlee CulverBozeman$2K
- Christopher CrowleyBozeman$542
- Alyson ThedeBozeman$447
- Suzanne SchoelchBozeman$198
- Jeffrey WilliamsBozeman$166
- Shannon SetzerBozeman$87
- Neil SwansonMissoula$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.